Current Oncology | Top Cited Papers in 2021 in the Section “Thoracic Oncology”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Thoracic Oncology” listed below:

1. “The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review”
by Goulnar Kasymjanova, Aksa Anwar, Victor Cohen, Khalil Sultanem, Carmela Pepe, Lama Sakr, Jennifer Friedmann and Jason S. Agulnik
Curr. Oncol. 2021, 28(6), 4247–4255; https://doi.org/10.3390/curroncol28060360
Available online: https://www.mdpi.com/1718-7729/28/6/360

2. “Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada”
by Dylan E. O’Sullivan, Winson Y. Cheung, Iqra A. Syed, Daniel Moldaver, Mary Kate Shanahan, D. Gwyn Bebb, Christina Sit, Darren R. Brenner and Devon J. Boyne
Curr. Oncol. 2021, 28(4), 3091–3103; https://doi.org/10.3390/curroncol28040270
Available online: https://www.mdpi.com/1718-7729/28/4/270

3. “Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System”
by Maisam Makarem, Doreen A. Ezeife, Adam C. Smith, Janice J. N. Li, Jennifer H. Law, Ming-Sound Tsao and Natasha B. Leighl
Curr. Oncol. 2021, 28(5), 3268–3279; https://doi.org/10.3390/curroncol28050284
Available online: https://www.mdpi.com/1718-7729/28/5/284

4. “Immunotherapy in Extensive-Stage Small Cell Lung Cancer”
by Rola El Sayed, and Normand Blais
Curr. Oncol. 2021, 28(5), 4093–4108; https://doi.org/10.3390/curroncol28050347
Available online: https://www.mdpi.com/1718-7729/28/5/347

5. “Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database”
by Heidi A. I. Grosjean, Samantha Dolter, Daniel E. Meyers, Philip Q. Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y. C. Heng, D. Gwyn Bebb et al.
Curr. Oncol. 2021, 28(5), 4213–4222; https://doi.org/10.3390/curroncol28050357
Available online: https://www.mdpi.com/1718-7729/28/5/357

6. “Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer”
by Christopher Cao, Anthony Le, Matthew Bott, Chi-Fu Jeffrey Yang, Dominique Gossot, Franca Melfi, David H. Tian and Allen Guo
Curr. Oncol. 2021, 28(6), 4686–4701; https://doi.org/10.3390/curroncol28060395
Available online: https://www.mdpi.com/1718-7729/28/6/395

7. “Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes”
by Sarah Sharman Moser, Jair Bar, Inna Kan, Keren Ofek, Raanan Cohen, Nikhil Khandelwal, Varda Shalev, Gabriel Chodick and Nava Siegelmann-Danieli
Curr. Oncol. 2021, 28(1), 317–331; https://doi.org/10.3390/curroncol28010036
Available online: https://www.mdpi.com/1718-7729/28/1/36

8. “Contribution of the Idylla^TM System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations”
by Constance Petiteau, Gwladys Robinet-Zimmermann, Adèle Riot, Marine Dorbeau, Nicolas Richard, Cécile Blanc-Fournier, Frédéric Bibeau, Simon Deshayes, Emmanuel Bergot, Radj Gervais et al.
Curr. Oncol. 2021, 28(6), 4432–4445; https://doi.org/10.3390/curroncol28060376
Available online: https://www.mdpi.com/1718-7729/28/6/376

9. “Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
by Koichi Ando, Ryo Manabe, Yasunari Kishino, Sojiro Kusumoto, Toshimitsu Yamaoka, Akihiko Tanaka, Tohru Ohmori, Tsukasa Ohnishi and Hironori Sagara
Curr. Oncol. 2021, 28(2), 1094–1113; https://doi.org/10.3390/curroncol28020106
Available online: https://www.mdpi.com/1718-7729/28/2/106

10. “Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic”
by Christopher J. L. Stone, Ana P. Johnson, Danielle Robinson, Andriy Katyukha, Rylan Egan, Sophia Linton, Christopher Parker, Andrew Robinson and Geneviève C. Digby
Curr. Oncol. 2021, 28(3), 1681–1695; https://doi.org/10.3390/curroncol28030157
Available online: https://www.mdpi.com/1718-7729/28/3/157